Target Price | $12.80 |
Price | $8.27 |
Potential |
54.78%
register free of charge
|
Number of Estimates | 5 |
5 Analysts have issued a price target Applied Therapeutics, Inc. 2025 .
The average Applied Therapeutics, Inc. target price is $12.80.
This is
54.78%
register free of charge
$14.00
69.29%
register free of charge
$11.00
33.01%
register free of charge
|
|
A rating was issued by 6 analysts: 6 Analysts recommend Applied Therapeutics, Inc. to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Applied Therapeutics, Inc. stock has an average upside potential 2025 of
54.78%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 9.99 | 2.13 |
78.65% | ||
EBITDA Margin | -642.44% | -3,704.02% |
476.55% | ||
Net Margin | -1,632.50% | -4,567.78% |
179.80% |
6 Analysts have issued a sales forecast Applied Therapeutics, Inc. 2024 . The average Applied Therapeutics, Inc. sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Applied Therapeutics, Inc. EBITDA forecast 2024. The average Applied Therapeutics, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
2 Applied Therapeutics, Inc. Analysts have issued a net profit forecast 2024. The average Applied Therapeutics, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -1.42 | -0.85 |
34.86% | 40.14% | |
P/E | negative | |
EV/Sales | 388.18 |
2 Analysts have issued a Applied Therapeutics, Inc. forecast for earnings per share. The average Applied Therapeutics, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Applied Therapeutics, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Applied Therapeutics, Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.